Customer identification and marketing strategy
Client Goal & Project
A pharmaceutical company engaged SURUS Consultancy to assess the clinical impact of a cardiovascular drug on the continuum of care. The ultimate goal was to provide clinical support for a marketing strategy and to identify use cases and clinical users for the drug.
Our approach
We performed an automated, systematic search using our SURUS model to identify clinical trials and observational studies that evaluated the drug in comparison with the standard of care. Based on this data, we quantitatively analyzed the added clinical value of the drug of interest. In addition, six medical experts were interviewed to verify the hypotheses formulated in the secondary research and to assess the clinical relevance of the drug of interest.
Results
SURUS screened over 3000 relevant publications and identified 27 studies that investigated the drug of interest. The quantitative analysis revealed that the drug of interest is superior in regards to effect and impact on hemodynamic parameters. This was discussed with the medical experts resulting in an overview of cases when the drug is preferred over its competitors. This information was then used to draft marketing materials for the client team.
A comparative analysis showed how the drug of interest performed better than the current standard of care in bringing 4 out of 6 altered parameters back to normal values.
Expert interviews helped SURUS identify the appropriate targets for the client’s marketing strategy in order to drive adoption of newer treatments with the drug of interest.
SURUS Consultancy’s insights enabled the client to identify new potential customers and a competitive marketing strategy for the drug of interest.
Do you have a healthcare question for SURUS Consultancy? Read more on the SURUS Consultancy page or contact the team.
Will named entity recognition make reading obsolete?
At Medstone, we develop artificial intelligence solutions for analyzing and visualizing medical scientific information. We createese solutions for pharmacists, healthcare professionals, biotech companies and pharmaceutical companies.
09/11/2020
Read more